Elyse Stock - Net Worth and Insider Trading
Elyse Stock Net Worth
The estimated net worth of Elyse Stock is at least $135,928 dollars as of 2024-09-13. Elyse Stock is the Chief Medical Officer of Biohaven Pharmaceutical Holding Co Ltd and owns about 9,654 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $135,928. Details can be seen in Elyse Stock's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Elyse Stock has not made any transactions after 2021-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Elyse Stock
Elyse Stock Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Elyse Stock owns 1 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) .
Click here to see the complete history of Elyse Stock’s form 4 insider trades.
Insider Ownership Summary of Elyse Stock
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2021-12-15 | Chief Medical Officer |
Elyse Stock Latest Holdings Summary
Elyse Stock currently owns a total of 1 stock. Elyse Stock owns 9,654 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of December 15, 2021, with a value of $135,928.
Latest Holdings of Elyse Stock
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2021-12-15 | 9,654 | 14.08 | 135,928 |
Holding Weightings of Elyse Stock
Elyse Stock Form 4 Trading Tracker
According to the SEC Form 4 filings, Elyse Stock has made a total of 4 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the sale of 28,858 shares on December 15, 2021, which brought Elyse Stock around $3 Million.
Insider Trading History of Elyse Stock
- 1
Elyse Stock Trading Performance
Elyse Stock Ownership Network
Elyse Stock Owned Company Details
What does Biohaven Pharmaceutical Holding Co Ltd do?
Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?
Elyse Stock is the Chief Medical Officer of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include VP & Chief Accounting Officer George C. Clark , Chief Financial Officer James Engelhart , and Officer Matthew Buten .
Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biohaven Pharmaceutical Holding Co Ltd Insider Transactions
Elyse Stock Mailing Address
Above is the net worth, insider trading, and ownership report for Elyse Stock. You might contact Elyse Stock via mailing address: 215 Church Street New Haven Ct 06510.